Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christobel Saunders

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boostJayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2016
Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trialVeronica F Quinn, Bettina Meiser, Judy Kirk, et al.
Breast (Edinburgh, Scotland)|February 10, 2015
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?Olivia Pagani, Monica Ruggeri, Silvia Manunta, et al.
Lancet (London, England)|June 24, 2010
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trialJayant S Vaidya, David J Joseph, Jeffrey S Tobias, et al.
Breast Cancer Research : BCR|March 2, 2006
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resourceGraham J Mann, Heather Thorne, Rosemary L Balleine, et al.
Lancet (London, England)|November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialJayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Bioengineering (Basel, Switzerland)|November 27, 2025
Development of a Machine Learning Model for Predicting Treatment-Related Amenorrhea in Young Women with Breast CancerLong Song, Zobaida Edib, Uwe Aickelin, et al.
BMJ (Clinical Research Ed.)|August 21, 2020
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialJayant S Vaidya, Max Bulsara, Michael Baum, et al.
JAMA Oncology|December 30, 2016
A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) InitiativeWee Loon Ong, Maartje G Schouwenburg, Annelotte C M van Bommel, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boostJayant S Vaidya, Michael Baum, Jeffrey S Tobias, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2016
Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trialVeronica F Quinn, Bettina Meiser, Judy Kirk, et al.
Breast (Edinburgh, Scotland)|February 10, 2015
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?Olivia Pagani, Monica Ruggeri, Silvia Manunta, et al.
Lancet (London, England)|June 24, 2010
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trialJayant S Vaidya, David J Joseph, Jeffrey S Tobias, et al.
Breast Cancer Research : BCR|March 2, 2006
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resourceGraham J Mann, Heather Thorne, Rosemary L Balleine, et al.
Lancet (London, England)|November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialJayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.
Bioengineering (Basel, Switzerland)|November 27, 2025
Development of a Machine Learning Model for Predicting Treatment-Related Amenorrhea in Young Women with Breast CancerLong Song, Zobaida Edib, Uwe Aickelin, et al.
BMJ (Clinical Research Ed.)|August 21, 2020
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialJayant S Vaidya, Max Bulsara, Michael Baum, et al.
JAMA Oncology|December 30, 2016
A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) InitiativeWee Loon Ong, Maartje G Schouwenburg, Annelotte C M van Bommel, et al.
Pageof 18